CNSP insider trading — CNS Pharmaceuticals, Inc.
Over the last 90 days, insiders at CNS Pharmaceuticals, Inc. (CNSP) made 1 open-market purchase worth $10K and 0 open-market sales worth $0, making them net buyers by $10K. The largest purchase was by Fisher Michal (Director), who bought 2,000 shares for $10K on May 18, 2026.
Updated Oct 16, 2026.
Recent CNSP insider transactions
Every Form 4 filed by CNS Pharmaceuticals, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Fisher Michal | Director | P · Purchase | Direct | 2,000 | $5.00 | $10K | Form 4 |
| Aug 14, 2026 | Levin Rami | CEO and President | M · Option exercise | Direct | 4,750 | — | — | Form 4 |
CNSP insider trading FAQ
Are insiders buying CNSP stock?
Yes. In the last 90 days, CNS Pharmaceuticals, Inc. insiders made 1 open-market purchase totaling $10K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading CNSP?
Recent buyers: Fisher Michal.
Where does CNSP insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.